Patents Assigned to Superb Wisdom Limited
  • Derivatives of resiquimod
    Patent number: 12077535
    Abstract: A deuterated compound having structural formula I or a pharmaceutically acceptable salt thereof: Values and example values of the variable in formula (I) are disclosed herein. Also disclosed are the use of compounds of formula (I) in the methods of treating a disease selected from cancer, an autoimmune disease, and an infectious disease, and methods of enhancing an immune response to an antigen.
    Type: Grant
    Filed: February 4, 2022
    Date of Patent: September 3, 2024
    Assignee: SUPERB WISDOM LIMITED
    Inventor: Lihu Yang
  • Derivatives of Resiquimod
    Patent number: 11274099
    Abstract: A deuterated compound having structural formula I or a pharmaceutically acceptable salt thereof: Values and example values of the variable in formula (I) are disclosed herein. Also disclosed are the use of compounds of formula (I) in the methods of treating a disease selected from cancer, an autoimmune disease, and an infectious disease, and methods of enhancing an immune response to an antigen.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: March 15, 2022
    Assignee: Superb Wisdom Limited
    Inventor: Lihu Yang